| 1 |
31107542 | Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial. | 2019 Dec 1 |
1 |
| 2 |
31756062 | Association of XPD Asp312Asn polymorphism and response to oxaliplatin-based first-line chemotherapy and survival in patients with metastatic colorectal cancer. | 2019 Nov |
2 |
| 3 |
28088319 | ERCC1 and ERCC2 as predictive biomarkers to oxaliplatin-based chemotherapy in colorectal cancer patients from Egypt. | 2017 Feb |
2 |
| 4 |
26261061 | AGXT and ERCC2 polymorphisms are associated with clinical outcome in metastatic colorectal cancer patients treated with 5-FU/oxaliplatin. | 2016 Jun |
1 |
| 5 |
24590266 | XRCC1 and XPD genetic polymorphisms and clinical outcomes of gastric cancer patients treated with oxaliplatin-based chemotherapy: a meta-analysis. | 2014 Jun |
2 |
| 6 |
25520091 | The XPD Lys751Gln polymorphism has predictive value in colorectal cancer patients receiving oxaliplatin-based chemotherapy: a systemic review and meta-analysis. | 2014 |
6 |
| 7 |
22994779 | GSTP1, ERCC1 and ERCC2 polymorphisms, expression and clinical outcome of oxaliplatin-based adjuvant chemotherapy in colorectal cancer in Chinese population. | 2012 |
3 |
| 8 |
24833529 | ERCC1 and XPD/ERCC2 polymorphisms' predictive value of oxaliplatin-based chemotherapies in advanced colorectal cancer has an ethnic discrepancy: a meta-analysis. | 2012 Jan |
2 |
| 9 |
21278243 | ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. | 2011 Mar 15 |
3 |
| 10 |
21999595 | mRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury. | 2011 Nov |
1 |
| 11 |
20078613 | Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients. | 2010 Jan |
1 |
| 12 |
19432884 | Very low prevalence of XPD K751Q polymorphism and its association with XPD expression and outcomes of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. | 2009 Jul |
2 |
| 13 |
18085999 | Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome. | 2007 Dec |
5 |
| 14 |
18204222 | Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. | 2007 |
2 |
| 15 |
16773204 | Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. | 2006 Jul |
1 |